PFSA Profusa, Inc. Common Stock
Healthcare$0.38+1.65%ClosedMarket Cap: $209,465
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-0.02
P/S
0.00
EV/EBITDA
-0.36
DCF Value
$-55.30
FCF Yield
-8819.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
154.2%
ROA
-4920.2%
ROIC
193.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-3.5M | $— |
| Q4 null | $0.00 | $-8.6M | $— |
| FY null | $0.00 | $-35.8M | $— |
| Q3 null | $0.00 | $-22.2M | $— |
Trading Activity
Insider Trades
View AllSTOVER JACK Edirector
BuyWed May 06
Knechtel Fred S.officer: Chief Financial Officer
BuyTue May 05
NorthView Sponsor I, LLC10 percent owner
SellMon Feb 02
NorthView Sponsor I, LLC10 percent owner
SellMon Feb 02
Knechtel Fred S.officer: Chief Financial Officer
SellMon Feb 02
Company Info
Sector
Healthcare
Industry
Medical - Equipment & Services
Country
US
Exchange
—
Beta
0.45
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia